ARTICLE | Company News
Active Biotech, Teva deal
February 15, 2010 8:00 AM UTC
Teva will now have exclusive, worldwide rights to develop and commercialize Active Biotech's laquinimod. The companies added the Nordic and Baltic regions, which were excluded from the original 2004 d...